Skip to main content
AppaltiWatch

RINNOVO CONTRATTO DI FORNITURA IN SERVICE DI UN SISTEMA PER IL DOSAGGIO DELLE VIREMIE HIV-HCV-HBV OCCORRENTE ALLA SOS DI AUTOIMMUNITÀ, ALLERGOLOGIA E BIOTECNOLOGIE INNOVATIVE DELL'ASMN. POS. 5/272-2022

AZIENDA UNITA' SANITARIA LOCALE DI REGGIO EMILIA

CIG 9324863062Verify on ANACEmilia-Romagna · Reggio nell'EmiliaGoods / suppliesOpen procedureCPV 33124110-9Risk signal — not an accusation of crime.
At a glance
Key figures from open ANAC records for this contract.

Amount

€195,224

Award date

23 Aug 2022

Bids

1

Published

15 Jul 2022

Estimated tender value

€230,000

Sector (CPV)

SISTEMI DIAGNOSTICI
Timeline

  1. Publication / start of procedure

    15 Jul 2022

    Step completed

  2. Time to submit bids

    22 Jul 2022

    7 days between opening and deadline

    Step completed

  3. Award

    23 Aug 2022

In plain language

These are automated checks on public data. They help you decide what to look into — they are not criminal findings.

This contract triggered 5 pattern(s) worth a closer look:

Low competition · Tight deadlines

Contracting authority (buyer)
AZIENDA UNITA' SANITARIA LOCALE DI REGGIO EMILIA

Emilia-Romagna · More tenders in this area

AUSA code: 0000187277

REGGIO NELL'EMILIA

Authority profile
Awarded to (suppliers)
1 award line(s) on record.
SupplierRegionAmountAward dateStatus
ROCHE DIAGNOSTICS S.P.A.—€195,22423 Aug 2022AGGIUDICATA
How do I verify this tender?

Loading actions…

Similar tenders in the same area

Loading comparison…

Sector comparison

Loading…

Amount vs category

Loading…

Citizen verifier notes
Share what you verified on official sources — not a verdict
How the score is built
Ruleset 2.0.0 · 6 Jul 2026
Source data & verification

ANAC BDNCP — dati tabellari

Verify on ANAC

Ingested: 6 Jul 2026

Release: 20260501-cig_csv.csv

Days to submit bids: 7

RINNOVO CONTRATTO DI FORNITURA IN SERVICE DI UN SISTEMA PER IL DOSAGGIO DELLE VIREMIE HIV-HCV-HBV OCCORRENTE ALLA SOS DI AUTOIMMUNITÀ, ALLERGOLOGIA E BIOTECNOLOGIE INNOVATIVE DELL'ASMN. POS. 5/272-2022 — AppaltiWatch